National Toxicology Program, National Institute of Environmental Health Sciences, Durham, North Carolina 27709.
Department of Pharmacology and Toxicology, University of Arizona, Tucson, Arizona 85721.
Toxicol Sci. 2020 Jul 1;176(1):1-10. doi: 10.1093/toxsci/kfaa060.
There is an increasing awareness that the gut microbiome plays a critical role in human health and disease, but mechanistic insights are often lacking. In June 2018, the Health and Environmental Sciences Institute (HESI) held a workshop, "The Gut Microbiome: Markers of Human Health, Drug Efficacy and Xenobiotic Toxicity" (https://hesiglobal.org/event/the-gut-microbiome-workshop) to identify data gaps in determining how gut microbiome alterations may affect human health. Speakers and stakeholders from academia, government, and industry addressed multiple topics including the current science on the gut microbiome, endogenous and exogenous metabolites, biomarkers, and model systems. The workshop presentations and breakout group discussions formed the basis for identifying data gaps and research needs. Two critical issues that emerged were defining the microbial composition and function related to health and developing standards for models, methods and analysis in order to increase the ability to compare and replicate studies. A series of key recommendations were formulated to focus efforts to further understand host-microbiome interactions and the consequences of exposure to xenobiotics as well as identifying biomarkers of microbiome-associated disease and toxicity.
人们越来越意识到肠道微生物组在人类健康和疾病中起着关键作用,但缺乏机制上的深入了解。2018 年 6 月,健康与环境科学协会(HESI)举办了一场题为“肠道微生物组:人类健康、药物疗效和外源性毒物毒性的标志物”的研讨会(https://hesiglobal.org/event/the-gut-microbiome-workshop),以确定在确定肠道微生物组的改变如何可能影响人类健康方面存在的数据空白。来自学术界、政府和工业界的演讲者和利益相关者讨论了多个主题,包括肠道微生物组的当前科学、内源性和外源性代谢物、生物标志物和模型系统。研讨会的演讲和分组讨论为确定数据空白和研究需求奠定了基础。出现的两个关键问题是定义与健康相关的微生物组成和功能,以及制定模型、方法和分析的标准,以提高比较和复制研究的能力。制定了一系列关键建议,集中精力进一步了解宿主-微生物组相互作用以及暴露于外源性毒物的后果,以及确定与微生物组相关疾病和毒性的生物标志物。